Co-Authors
This is a "connection" page, showing publications co-authored by Mary Ramsay and Felicity Aiano.
Connection Strength
1.827
-
Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study. PLoS One. 2021; 16(8):e0255517.
Score: 0.241
-
Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England. J Infect. 2021 11; 83(5):573-580.
Score: 0.240
-
SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020. EClinicalMedicine. 2021 Jul; 37:100948.
Score: 0.237
-
COVID-19 outbreaks following full reopening of primary and secondary schools in England: Cross-sectional national surveillance, November 2020. Lancet Reg Health Eur. 2021 Jul; 6:100120.
Score: 0.237
-
SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study. Lancet Child Adolesc Health. 2021 06; 5(6):417-427.
Score: 0.234
-
Secondary Attack Rate and Family Clustering of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children of Healthcare Workers With Confirmed Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 07 01; 73(1):e260-e263.
Score: 0.060
-
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021 Jul; 22(7):928.
Score: 0.060
-
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers. J Infect. 2021 05; 82(5):162-169.
Score: 0.058
-
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021 05; 22(5):620-626.
Score: 0.058
-
Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation. Lancet Reg Health Eur. 2021 Mar; 2:100015.
Score: 0.058
-
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England. Clin Infect Dis. 2021 03 01; 72(5):e65-e75.
Score: 0.058
-
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill. 2021 02; 26(5).
Score: 0.058
-
Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19: Prospective observational cohort study, England 2020. Lancet Reg Health Eur. 2021 Apr; 3:100038.
Score: 0.058
-
High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England. EClinicalMedicine. 2020 Nov; 28:100597.
Score: 0.057
-
Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020. EClinicalMedicine. 2020 Sep; 26:100533.
Score: 0.056
-
Increased risk of SARS-CoV-2 infection in staff working across different care homes: enhanced CoVID-19 outbreak investigations in London care Homes. J Infect. 2020 Oct; 81(4):621-624.
Score: 0.056